GoodRx Holdings (GDRX) Cash from Investing Activities (2019 - 2026)

GoodRx Holdings has reported Cash from Investing Activities for 8 years, with the latest figure at -$21.6 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 58.28% year-over-year to -$21.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$89.7 million (up 11.69% YoY) and the FY2025 annual result came in at -$120.0 million, down 70.53% from the prior year.
• Cash from Investing Activities improved to -$21.6 million in Q1 2026 per GDRX's latest filing, from -$31.8 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $1.3 million in Q4 2022 and troughed at -$163.6 million in Q2 2022.
• A 5-year average of -$28.1 million and a median of -$17.2 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities jumped 113.89% in 2022, then sank 1100.93% in 2023.
• Over 5 years, Cash from Investing Activities stood at $1.3 million in 2022, then tumbled by 1100.93% to -$12.9 million in 2023, then slipped by 29.3% to -$16.6 million in 2024, then tumbled by 90.88% to -$31.8 million in 2025, then jumped by 31.87% to -$21.6 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$21.6 million, -$31.8 million, and -$18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.